According to Entera Bio's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.5. At the end of 2024 the company had a P/S ratio of 737.
Year | P/S ratio | Change |
---|---|---|
2024 | 737 | |
2023 | N/A | -100% |
2022 | 157 | 10.52% |
2021 | 142 | 127.91% |
2020 | 62.3 | -61.54% |
2019 | 162 | 131.73% |
2018 | 69.9 |